The latest study on Wet Age Related Macular Degeneration (AMD) Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Wet Age Related Macular Degeneration (AMD) Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Wet Age Related Macular Degeneration (AMD) and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Novartis International (Switzerland)
Bayer (Germany)
Acucela (US)
Neurotech Pharmaceuticals (US)
Ophthotech (US)
GlaxoSmithKline (US)
Alimera Sciences (US)
StemCell (Canada)
F. Hoffmann-La Roche (Switzerland)
Regeneron Pharmaceutical (US)
Allergan (Ireland)
Adverum Biotechnologies (US)
Gilead Sciences (US)
Wet Age Related Macular Degeneration (AMD) Market Analysis By Type Segment:
Wet Age-Related Macular Degeneration (Wet AMD)
Dry Age-Related Macular Degeneration (Dry AMD)
Wet Age Related Macular Degeneration (AMD) Market Analysis By Application Segment:
>75 Years
>60 Years
>40 Years
Wet Age Related Macular Degeneration (AMD) Market Analysis By Regions (Countries):
The Wet Age Related Macular Degeneration (AMD) Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Wet Age Related Macular Degeneration (AMD) Report:
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Wet Age Related Macular Degeneration (AMD) Market:
Wet Age Related Macular Degeneration (AMD) market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Wet Age Related Macular Degeneration (AMD) Market
What is the expected Market size and growth rate of the Wet Age Related Macular Degeneration (AMD) market for the forecast period
Where is the largest and fastest growing market for Wet Age Related Macular Degeneration (AMD) market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Wet Age Related Macular Degeneration (AMD) market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Wet Age Related Macular Degeneration (AMD) Market status and future forecast.
To present the key Wet Age Related Macular Degeneration (AMD) Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Frequently Asked Questions - FAQ:
How big is the opportunity for the Wet Age Related Macular Degeneration (AMD) market
Which are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Wet Age Related Macular Degeneration (AMD) market Which companies are the front runners
What are the major end-use industries of Wet Age Related Macular Degeneration (AMD) market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (2016-2027)
1.4.2 Wet Age-Related Macular Degeneration (Wet AMD)
1.4.3 Dry Age-Related Macular Degeneration (Dry AMD)
1.5 Market by Application
1.5.1 Global Wet Age Related Macular Degeneration (AMD) Market Share by Application (2016-2027)
1.5.2 >75 Years
1.5.3 >60 Years
1.5.4 >40 Years
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Wet Age Related Macular Degeneration (AMD) Market Size
2.2 Wet Age Related Macular Degeneration (AMD) Growth Trends by Regions
2.2.1 Wet Age Related Macular Degeneration (AMD) Market Size by Regions (2016-2027)
2.2.2 Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Wet Age Related Macular Degeneration (AMD) Market Size by Manufacturers
3.1.1 Global Wet Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2016-2020)
3.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Manufacturers (2016-2020)
3.1.3 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.2 Wet Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.3 Key Players Wet Age Related Macular Degeneration (AMD) Product/Solution/Service
3.4 Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020)
4.2 Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020)
5 United States
5.1 United States Wet Age Related Macular Degeneration (AMD) Market Size (2016-2020)
5.2 Wet Age Related Macular Degeneration (AMD) Key Players in United States
5.3 United States Wet Age Related Macular Degeneration (AMD) Market Size by Type
5.4 United States Wet Age Related Macular Degeneration (AMD) Market Size by Application
6 Europe
6.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size (2016-2020)
6.2 Wet Age Related Macular Degeneration (AMD) Key Players in Europe
6.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type
6.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application
7 China
7.1 China Wet Age Related Macular Degeneration (AMD) Market Size (2016-2020)
7.2 Wet Age Related Macular Degeneration (AMD) Key Players in China
7.3 China Wet Age Related Macular Degeneration (AMD) Market Size by Type
7.4 China Wet Age Related Macular Degeneration (AMD) Market Size by Application
8 Japan
8.1 Japan Wet Age Related Macular Degeneration (AMD) Market Size (2016-2020)
8.2 Wet Age Related Macular Degeneration (AMD) Key Players in Japan
8.3 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Type
8.4 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size (2016-2020)
9.2 Wet Age Related Macular Degeneration (AMD) Key Players in Southeast Asia
9.3 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type
9.4 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Application
10 India
10.1 India Wet Age Related Macular Degeneration (AMD) Market Size (2016-2020)
10.2 Wet Age Related Macular Degeneration (AMD) Key Players in India
10.3 India Wet Age Related Macular Degeneration (AMD) Market Size by Type
10.4 India Wet Age Related Macular Degeneration (AMD) Market Size by Application
11 Central & South America
11.1 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size (2016-2020)
11.2 Wet Age Related Macular Degeneration (AMD) Key Players in Central & South America
11.3 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Type
11.4 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Application
12 International Players Profiles
12.1 Novartis International (Switzerland)
12.1.1 Novartis International (Switzerland) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.1.4 Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.1.5 Novartis International (Switzerland) Recent Development
12.2 Bayer (Germany)
12.2.1 Bayer (Germany) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.2.4 Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.2.5 Bayer (Germany) Recent Development
12.3 Acucela (US)
12.3.1 Acucela (US) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.3.4 Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.3.5 Acucela (US) Recent Development
12.4 Neurotech Pharmaceuticals (US)
12.4.1 Neurotech Pharmaceuticals (US) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.4.4 Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.4.5 Neurotech Pharmaceuticals (US) Recent Development
12.5 Ophthotech (US)
12.5.1 Ophthotech (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.5.4 Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.5.5 Ophthotech (US) Recent Development
12.6 GlaxoSmithKline (US)
12.6.1 GlaxoSmithKline (US) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.6.4 GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.6.5 GlaxoSmithKline (US) Recent Development
12.7 Alimera Sciences (US)
12.7.1 Alimera Sciences (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.7.4 Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.7.5 Alimera Sciences (US) Recent Development
12.8 StemCell (Canada)
12.8.1 StemCell (Canada) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.8.4 StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.8.5 StemCell (Canada) Recent Development
12.9 F. Hoffmann-La Roche (Switzerland)
12.9.1 F. Hoffmann-La Roche (Switzerland) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.9.4 F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.9.5 F. Hoffmann-La Roche (Switzerland) Recent Development
12.10 Regeneron Pharmaceutical (US)
12.10.1 Regeneron Pharmaceutical (US) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.10.4 Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
12.10.5 Regeneron Pharmaceutical (US) Recent Development
12.11 Allergan (Ireland)
12.12 Adverum Biotechnologies (US)
12.13 Gilead Sciences (US)
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Wet Age Related Macular Degeneration (AMD) Key Market Segments
Table Key Players Wet Age Related Macular Degeneration (AMD) Covered
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type 2016-2027
Figure Wet Age-Related Macular Degeneration (Wet AMD) Figures
Table Key Players of Wet Age-Related Macular Degeneration (Wet AMD)
Figure Dry Age-Related Macular Degeneration (Dry AMD) Figures
Table Key Players of Dry Age-Related Macular Degeneration (Dry AMD)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Growth by Application 2016-2027 (Million US$)
Figure >75 Years Case Studies
Figure >60 Years Case Studies
Figure >40 Years Case Studies
Figure Wet Age Related Macular Degeneration (AMD) Report Years Considered
Table Global Wet Age Related Macular Degeneration (AMD) Market Size 2016-2027 (Million US$)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions 2016-2027 (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions 2016-2020 (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2016-2020
Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2016-2020
Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2020
Table Market Top Trends
Table Global Wet Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2016-2020) (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Share by Manufacturers (2016-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Manufacturers in 2020
Table Global Wet Age Related Macular Degeneration (AMD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Wet Age Related Macular Degeneration (AMD) Product/Solution/Service
Table Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Type (2016-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2020)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Application (2016-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2016-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Application in 2020
Figure United States Wet Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table United States Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2019-2020) (Million US$)
Table United States Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2019-2020)
Table United States Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table United States Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table United States Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table United States Wet Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table Europe Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2019-2020) (Million US$)
Table Europe Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2019-2020)
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Europe Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Europe Wet Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure China Wet Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table China Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2019-2020) (Million US$)
Table China Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2019-2020)
Table China Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table China Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table China Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table China Wet Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure Japan Wet Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table Japan Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2019-2020) (Million US$)
Table Japan Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2019-2020)
Table Japan Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Japan Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table Japan Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Japan Wet Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2019-2020) (Million US$)
Table Southeast Asia Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2019-2020)
Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure India Wet Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table India Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2019-2020) (Million US$)
Table India Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2019-2020)
Table India Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table India Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table India Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table India Wet Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure Central & South America Wet Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2019-2020) (Million US$)
Table Central & South America Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2019-2020)
Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Table Novartis International (Switzerland) Company Details
Table Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020) (Million US$)
Figure Novartis International (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table Novartis International (Switzerland) Recent Development
Table Bayer (Germany) Company Details
Table Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure Bayer (Germany) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table Bayer (Germany) Recent Development
Table Acucela (US) Company Details
Table Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure Acucela (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table Acucela (US) Recent Development
Table Neurotech Pharmaceuticals (US) Company Details
Table Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure Neurotech Pharmaceuticals (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table Neurotech Pharmaceuticals (US) Recent Development
Table Ophthotech (US) Company Details
Table Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure Ophthotech (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table Ophthotech (US) Recent Development
Table GlaxoSmithKline (US) Company Details
Table GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure GlaxoSmithKline (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table GlaxoSmithKline (US) Recent Development
Table Alimera Sciences (US) Company Details
Table Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure Alimera Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table Alimera Sciences (US) Recent Development
Table StemCell (Canada) Company Details
Table StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure StemCell (Canada) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table StemCell (Canada) Recent Development
Table F. Hoffmann-La Roche (Switzerland) Company Details
Table F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table F. Hoffmann-La Roche (Switzerland) Recent Development
Table Regeneron Pharmaceutical (US) Company Details
Table Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)(Million US$)
Figure Regeneron Pharmaceutical (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2016-2020)
Table Regeneron Pharmaceutical (US) Recent Development
Table Allergan (Ireland) Company Details
Table Adverum Biotechnologies (US) Company Details
Table Gilead Sciences (US) Company Details
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions (Million US$) 2021-2027
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Regions (2021-2027)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Regions in 2027
Figure United States Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure China Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure Japan Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure India Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Product (2021-2027) (Million US$)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Product (2021-2027)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Product in 2027
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2021-2027) (Million US$)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2021-2027)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources